acebutolol has been researched along with Aging in 5 studies
Acebutolol: A cardioselective beta-1 adrenergic antagonist with little effect on the bronchial receptors. The drug has stabilizing and quinidine-like effects on cardiac rhythm, as well as weak inherent sympathomimetic action.
acebutolol : An ether that is the 2-acetyl-4-(butanoylamino)phenyl ether of the primary hydroxy group of 3-(propan-2-ylamino)propane-1,2-diol.
Aging: The gradual irreversible changes in structure and function of an organism that occur as a result of the passage of time.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Acebutolol (AC) is a chiral beta-blocker that is metabolized to an equipotent chiral metabolite, diacetolol (DC)." | 5.28 | Effect of aging on the pharmacokinetics of acebutolol enantiomers. ( Foster, RT; Jamali, F; Kappagoda, CT; Piquette-Miller, M, 1992) |
| "The results of a multi-centre general practice study on acebutolol in the treatment of hypertension were examined for two age groups of patients, namely those aged from 50 to 64 years and those aged 65 years and over." | 3.66 | Multi-centre study of acebutolol in hypertensive subjects: results for patients from the 50 to 64-years' old and over 65 years' old age groups. ( Baker, PG; Goulton, J; Guerin, A, 1981) |
| "Acebutolol (AC) is a chiral beta-blocker that is metabolized to an equipotent chiral metabolite, diacetolol (DC)." | 1.28 | Effect of aging on the pharmacokinetics of acebutolol enantiomers. ( Foster, RT; Jamali, F; Kappagoda, CT; Piquette-Miller, M, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ertan-Bolelli, T | 1 |
| Bolelli, K | 1 |
| Guerin, A | 1 |
| Baker, PG | 1 |
| Goulton, J | 1 |
| Watson, RD | 1 |
| Stallard, TJ | 1 |
| Littler, WA | 1 |
| Piquette-Miller, M | 1 |
| Foster, RT | 1 |
| Kappagoda, CT | 1 |
| Jamali, F | 1 |
| Weiss, Y | 1 |
| Chenard, A | 1 |
| De Kermadec, JM | 1 |
| Tertrain, F | 1 |
| Abiteboul, M | 1 |
1 trial available for acebutolol and Aging
| Article | Year |
|---|---|
Maintenance of blood pressure control in elderly hypertensives on ketoprofen.
Topics: Acebutolol; Aged; Aged, 80 and over; Aging; Atenolol; Blood Pressure; Double-Blind Method; Drug Ther | 1991 |
4 other studies available for acebutolol and Aging
| Article | Year |
|---|---|
In Silico Design of Novel Sirtuin 1 Enzyme Activators for the Treatment of Age-related Diseases and Life Span.
Topics: Acebutolol; Age Factors; Aging; Drug Design; Drug Discovery; Enzyme Activators; Humans; Longevity; M | 2021 |
Multi-centre study of acebutolol in hypertensive subjects: results for patients from the 50 to 64-years' old and over 65 years' old age groups.
Topics: Acebutolol; Aged; Aging; Blood Pressure; Female; Humans; Hypertension; Male; Middle Aged; Pulse; Tim | 1981 |
Effects of beta-adrenoreceptor antagonists on sino-aortic baroreflex sensitivity and blood pressure in hypertensive man.
Topics: Acebutolol; Adolescent; Adrenergic beta-Agonists; Adult; Aging; Blood Pressure; Female; Heart Rate; | 1979 |
Effect of aging on the pharmacokinetics of acebutolol enantiomers.
Topics: Acebutolol; Aged; Aging; Blood Proteins; Female; Humans; Isomerism; Kidney; Male; Middle Aged; Prote | 1992 |